Akzo Nobel N.V (AKZA) | Stock Overview & Key Data
Akzo Nobel N.V. | Large-cap | Basic Materials
Akzo Nobel N.V. | Large-cap | Basic Materials
Akzo Nobel N.V Performance Comparison
Stock Range
Today's Range
Low: €55.44
High: €56.04
on August 8, 2025
52 Week Range
Low: €48.64
High: €64.68
on April 11, 2025
on September 27, 2024
All-Time High: €108.45 on July 12, 2021
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Market Cap
€9.6B
EPS
2.40
P/E Ratio (TTM)
23.12
Forward P/E
12.25
P/B Ratio
2.27
PEG Ratio
12.25
Div. Yield
N/A
ROE
10.16%
Beta
1.001
Debt to Equity
133.32
Financial Highlights
Profitability
Gross Margin
39.53%
Operating Margin
8.45%
Profit Margin
3.94%
Returns and Earnings
Return on Assets (TTM)
3.70%
Return on Equity (TTM)
10.16%
EBITDA
€1.2B
Net Income (TTM)
€415.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€61.63
Quarterly Revenue Growth (YoY)
-5.70%
Quarterly Earnings Growth (YoY)
-29.90%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Akzo Nobel N.V AKZA | 9.55B Large-cap | 3.67% | -7.62% | -2.85% | -1.72% | -1.72% | 4.17% | -20.01% | -32.89% |
| DSM-Firmenich AG DSFIR | 21.30B Large-cap | 1.28% | -8.97% | -12.14% | -14.13% | -15.05% | -31.35% | -31.26% | -31.26% |
| IMCD N.V IMCD | 5.72B Large-cap | 2.54% | -14.47% | -18.71% | -35.29% | -32.06% | -30.42% | -36.58% | 8.13% |
| OCI N.V OCI | 1.58B Large-cap | 1.23% | -2.77% | -1.86% | -32.97% | -33.69% | -72.07% | -79.90% | -39.51% |
| Corbion N.V CRBN | 960.42M Mid-cap | 0.61% | -11.73% | -13.44% | -26.05% | -23.94% | -21.56% | -47.82% | -52.37% |
| Avantium N.V AVTX | 127.91M Small-cap | 3.82% | -5.20% | 39.00% | -17.34% | -23.40% | -41.58% | -47.12% | -70.67% |
Ownership & Short Interest
Insider Ownership
1.57%
Institutional Ownership
68.41%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
361K
Average 90-Day Volume
403K
Akzo Nobel N.V Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Akzo Nobel N.V would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AKZA's 52-week high and low?
- In the last 52 weeks, Akzo Nobel N.V reached a high of €64.68 (on September 27, 2024) and a low of €48.64 (on April 11, 2025).
- What is the market cap and P/E ratio for AKZA?
- Curious about Akzo Nobel N.V's size and valuation? Its market capitalization stands at 9.55B. When it comes to valuation, the P/E ratio (trailing twelve months) is 23.12, and the forward P/E (looking ahead) is 12.25.
- Does AKZA pay dividends? If so, what's the yield?
- As for dividends, Akzo Nobel N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Akzo Nobel N.V's main competitors or similar companies to consider before investing?
When looking at Akzo Nobel N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return DSM-Firmenich AG
DSFIR21.30B Basic Materials Specialty Chemicals -31.35% -31.26% IMCD N.V
IMCD5.72B Basic Materials Specialty Chemicals -30.42% -36.58% OCI N.V
OCI1.58B Basic Materials Specialty Chemicals -72.07% -79.90% Corbion N.V
CRBN960.42M Basic Materials Specialty Chemicals -21.56% -47.82% Avantium N.V
AVTX127.91M Basic Materials Specialty Chemicals -41.58% -47.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Akzo Nobel N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Akzo Nobel N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.16%, the Debt to Equity ratio from the most recent quarter is 133.32, and its Gross Profit Margin stands at 39.53%.
- What is the recent revenue and earnings growth for AKZA?
- Looking at Akzo Nobel N.V's growth, its revenue over the trailing twelve months (TTM) was €11B. Compared to the same quarter last year (YoY), quarterly revenue grew by -5.70%, and quarterly earnings saw a YoY growth of -29.90%.
- How much of AKZA stock is held by insiders and institutions?
- Wondering who owns Akzo Nobel N.V stock? Company insiders (like executives and directors) hold about 1.57% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 68.41%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.